Davidson Kempner Capital Management LP Paratek Pharmaceuticals, Inc. Transaction History

Davidson Kempner Capital Management LP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2017 Feb 14, 2018	SELL	$17.45 - $25.6 $2.18 Million - $3.2 Million	-125,036 Reduced 46.66%	142,965 $2.56 Million
Q3 2017 Nov 14, 2017	BUY	$18.9 - $28.2 $5.07 Million - $7.56 Million	268,001	268,001 $6.73 Million

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Davidson Kempner Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Davidson Kempner Capital Management LP with notifications on news.